← Back to Newsletter Archive

Welcome to the Monthly QPS Preclinical Newsletter


Discover QPS' extensive Global Regulatory Affairs services, explore our flexible approach to IND-enabling preclinical studies, and catch up on the latest breakthroughs and insights on the QPS blog.



Greetings!

Discover QPS Global Regulatory Affairs (GRA) Services

QPS Medical and Regulatory Affairs Departments are focused on partnering with pharmaceutical, biotech and medical device companies to ensure the successful development of their clinical drug development programs.


Our expertise encompasses discovery, preclinical, clinical, and commercial regulatory services to bring new therapies to patients faster.


We are committed to ensuring compliance and fostering innovation in the healthcare industry.

Download the White Paper


Understanding and Navigating Changes to Clinical Trial Management in the European Union


A Flexible Approach to IND Submissions

Partnering with QPS for a well-conceived and well-executed IND-enabling preclinical program will provide you with a detailed assessment of your drug candidate and the most agile, flexible and timely pathway to filing an IND.


Before we begin executing your IND-enabling preclinical program, you will receive a strategic review and advice on the design and execution of your ADME and pharmacology-toxicology studies.


During execution of your IND-enabling program you will benefit from QPS’s operational strengths, strong scientific/regulatory pre-IND/IND support, and drug development experience.

Explore the QPS White Paper


Confidently Choose A CRO to Support Your IND Efforts

Discover the Future of Science on the QPS Blog

Research Shows Coffee Drinkers May Enjoy Longer Lives


A fresh cup of coffee is a daily ritual for over 1 billion people around the world. Coffee isn’t just a morning treat; according to a new review study from researchers at the University of Coimbra in Portugal, drinking coffee regularly may...


Why Coffee Drinkers May Live Longer

Read More Innovative Blog Posts

Diet Changes to Slow Prostate Cancer? Omega-3 Study Has Promising Results

 

Men with early-stage prostate cancer may have a new tool to help slow disease progression. A Phase II trial led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a diet high in omega-3 fatty acids and low in...


A New Path Forward

The Ultimate Guide to Gene Therapy

Click Here to Subscribe to the QPS Blog

Will you be at any of the following conferences?

QPS would love to meet with you.


World ADC - Booth# 18

London, UK

March 3-6, 2025


WRIB - Booth# 47

New Orleans, LA

April 7-11, 2025


AAPS NBC - Booth# 212

New Orleans, LA

May 4-7, 2025


TIDES (Peptides and Oligonucleotides)

San Diego, CA

May 19-22, 2025

Schedule a Meeting with QPS

Visit our website www.qps.com 

or contact us at info@qps.com

for an appointment.

Linkedin  Youtube  Twitter  Facebook  

www.qps.cominfo@qps.com | +1 512 350 2827

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive